Cerence (CRNC) EVP granted 49,905 shares in Form 4 filing

Cerence Inc. (CRNC) reported an equity transaction by its EVP, Product & Technology.

Rhea-AI Filing Summary

Cerence Inc. (CRNC) reported an equity transaction by its EVP, Product & Technology. On 11/21/2025, the executive acquired 49,905 shares of Cerence common stock at $10.35 per share. After this transaction, the executive beneficially owns 254,886 shares directly.

The company notes this grant represents performance stock units (PSUs) achieved under the FY25 plan that are scheduled to vest in November 2027, tying the award to longer-term performance and retention.

Insider Trade Summary

Grant/Award: 49,905 shares

Grant/Award 1 txn

Insider Schanz Nils

Role EVP Product & Technology

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	49,905	$10.35	$517K

Holdings After Transaction: Common Stock — 254,886 shares (Direct)

Footnotes (1)

1. F1. This represents achieved PSUs under the FY25 plan that will vest in November 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cerence (CRNC) disclose in this Form 4 filing?

Cerence reported that its EVP, Product & Technology acquired 49,905 shares of common stock on 11/21/2025 at $10.35 per share.

Who is the insider involved in this Cerence (CRNC) Form 4?

The filing relates to a Cerence officer, serving as EVP Product & Technology, who reported the equity transaction.

How many Cerence (CRNC) shares does the executive own after the transaction?

Following the reported transaction, the executive beneficially owns 254,886 shares of Cerence common stock directly.

What type of award are the 49,905 Cerence (CRNC) shares?

The 49,905 shares represent achieved PSUs under the FY25 plan that are scheduled to vest in November 2027.

Does this Cerence (CRNC) Form 4 involve derivative securities?

The provided tables list only common stock in the non-derivative section, with no derivative securities reported in Table II.

What is the significance of the November 2027 date for Cerence (CRNC) PSUs?

The filing states the achieved PSUs under the FY25 plan are expected to vest in November 2027, reflecting a long-term vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 06:24 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schanz Nils

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Product & Technology

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		A		49,905(1)	A	$10.35	254,886	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This represents achieved PSUs under the FY25 plan that will vest in November 2027.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.